DC
Therapeutic Areas
Insulet Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Omnipod 5 Type 2 Expansion | Type 2 Diabetes (Adults) | Commercial |
| Omnipod 5 International Rollout | Type 1 & Type 2 Diabetes | Commercial |
| Next-Gen Hardware/Software | Diabetes Management | R&D |
| CGM Ecosystem Integration | Diabetes Management | Development/Regulatory |
Leadership Team at Insulet
JH
Jim Hollingshead, Ph.D.
President and Chief Executive Officer
WM
Wayde McMillan
Executive Vice President and Chief Financial Officer
BC
Bret Christensen
Chief Commercial Officer
DT
Dr. Trang Ly
Senior Vice President and Medical Director
MF
Mark Field
Chief Technology Officer
TS
Timothy Scannell
Chairman of the Board